Heart Attack(Acute Myocardial Infarction [AMI]; Myocardial Infarction [MI]; ST-Segment-Elevation MI [STEMI]; Transmural Myocardial infarction)
by
Rosalyn Carson-DeWitt, MD DefinitionA heart attack occurs when blood flow to the heart muscle is interrupted. Oxygen cannot get to the heart muscle, causing tissue damage or tissue death.
Causes TOPA heart attack may be caused by:
Risk Factors TOPThese factors increase your chance of developing heart attack. Tell your doctor if you have any of these:
Symptoms TOPSymptoms include:
Unusual symptoms of heart attack (may occur more frequently in women):
If you think you are having a heart attack, call 911 right away. Diagnosis TOPTests may include:
Treatment TOPTreatment includes:
Within the first six hours after a heart attack, you may be given medicines to break up blood clots in the coronary arteries. Other medicines that may be given include those that block the function of platelets. SurgeryIf you have severe blockages, you may need surgery, such as:
Physical or Rehabilitative TherapyDuring recovery, you may need physical or rehabilitative therapy to help you regain your strength. Prevention TOPPreventing or treating coronary artery disease may help prevent a heart attack.
RESOURCES:American Heart Association http://www.heart.org CANADIAN RESOURCESCollege of Family Physicians Canada http://www.cfpc.ca/Home/ Heart and Stroke Foundation http://www.heartandstroke.com/ References:
About heart attacks. American Heart Association website. Available at:
http://www.heart.o...
. Accessed August 7, 2012.
ST-elevation myocardial infarction (STEMI). EBSCO DynaMed website. Available at:
https://dynamed.ebscohost.com/about/about-us
. Updated June 7, 2012. Accessed August 7, 2012.
What is a heart attack? National Heart Lung and Blood Institute website. Available at:
http://www.nhlbi.n...
. Updated march 1, 2011. Accessed August 7, 2011.
7/6/2009 DynaMed's Systematic Literature Surveillance
https://dynamed.ebscohost.com/about/about-us
: Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials.
Lancet.
2009;373:1849-1860.
Last reviewed September 2012 by Michael J. Fucci, DO Last Updated: 09/10/2012 | |